All posts tagged
graft versus host disease
Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment
Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer
New Research could Save Patients from Graft-Versus-Host Disease
EMA Paves the Way for a New Blood Cancer Immunotherapy for Children
This Dutch Company is Upgrading ADCs for Immunotherapy
Better and Safer Bone Marrow Transplants for Leukemia enter Phase III
Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials
How is European Immuno-Oncology fighting Blood Cancer?
Will the Leading Italian Biotech soon have its First Cell therapy on the Market?
Dutch Leukemia Phase II Gets $1M Acceleration Funding from a Generous Charity
Labiotech UG, All Rights Reserved -
Send this to a friend